1. Methods are described for monitoring the metabolic flux through phenylalanine hydroxylase, the tyrosine catabolic pathway and phenylalanine: pyruvate transaminase in isolated liver cell incubations. 2. The relationship between hydroxylase flux and phenylalanine concentration is sigmoidal. 3. Glucagon increases hydroxylase activity at low, nelar-physiological, substrate concentrations only. The hormone does not affect the rate of formation of phenylpyruvate. 4. Experimental diabetes (for 10 days) increases phenylalanine catabolism, and this is further increased by glucagon. 5. These results are discussed in the light of the known mechanisms for control of phenylalanine hydroxylase activity in vitro.
Phenylalanine hydroxylase [L-phenylalanine, tetrahydropteridine: oxygen oxidoreductase (4-hydroxylating); EC 1.14.16.11 catalyses the first, and physiologically irreversible, step in phenylalanine catabolism:
L-Phenylalanine + tetrahydrobiopterin +°-2 L-tyrosine + dihydrobiopterin + H20 The enzyme has been purified from rat liver and its properties examined in detail in vitro (see Goodwin, 1979 , for general review). In particular, each subunit of the tetramer exists in both phosphorylated and non-phosphorylated forms, the phosphorylation being catalysed in vitro by the cyclic AMP-dependent protein kinase (Abita et al., 1976; Donlon & Kaufman, 1980) . In vivo, the three isoenzymic forms are explicable on the basis of differing degrees of phosphorylation (Donlon & Kaufman, 1980) . It has furthermore been recently shown that exposure to glucagon increases the extent of phosphorylation both in whole animals (Donlon & Kaufman, 1978) and in isolated liver cells (Abita et al., 1980) .
In the present paper we report a method for following phenylalanine metabolism in isolated cells. Use of this method reveals that glucagon increases flow through the phenylalanine hydroxylase step at physiologically relevant concentrations of the amino acid substrate, and that this effect is additive with the increased enzyme activity in cells from diabetic rats.
The rate of formation of phenylpyruvate and phenyl-lactate is approx. 10% of that of the hydroxylase flux in normal, fed rats, and is more responsive to phenylalanine concentration than to glucagon availability.
Materials and methods

Animals
Male Sprague-Dawley rats (University of Manchester breeding colony), weighing 180-220g, were used throughout. Animals were fed ad libitum (no. 1 maintenance diet; Cooper Nutritional Products, Witham, Essex, U.K.).
Diabetes was induced by the intravenous injection of streptozotocin [60mg/kg body wt., in 0.9% (w/v) NaCli. Glucosuria was checked with Clinistix (Ames Co., Stoke Poges, Slough, Bucks., U.K.) and diabetes was confirmed by plasma glucose measurement (> 16.5 mM; Krebs et al., 1963) . Diabetic animals were used 10 days after injection. described by Chen (1967 
Preparation and incubation ofcells
Isolated liver cells were prepared from rats essentially by the procedure described previously (Elliott et al., 1976) . Metabolic integrity was assessed by measurement of ATP content throughout incubations (Dickson & Pogson, 1977) .
Incubation procedures and the measurement of 14CO2 release were as described previously (Smith et al., 1978; Smith & Pogson, 1980 (Guroff & Abramowitz, 1967) . The resulting 3H20 was separated from excess [4-3Hlphenylalanine as follows. Each sample was added to a column of Amberlite CG-120. [H+ form; 200 mesh; 1.5 ml of a 60% (w/v) slurry] covered by 20mg of Norit GSX in a Pasteur pipette plugged with cotton wool. 3H20 was washed through with 1 ml of double-distilled water and was counted for radioactivity in scintillation cocktail 'T' (Guroff & Abramowitz, 1967) .
After collection of 14CO2 in the centre wells after acidification of cell suspensions incubated with [1-_4Clphenylalanine, the contents of each vial were centrifuged (3000g, 5 min, 40C). Portions (0.5 ml) of supernatants were added to 0.5 ml columns of Amberlite CG-120 (H+ form) in Pasteur pipettes.
The columns were washed with 0.5 ml of doubledistilled water and samples of the combined eluates were counted for radioactivity in cocktail 'T'. These eluates contain [1-14C] 
Results and discussion
Phenylalanine metabolism has been studied not only in vivo in man (Goodwin, 1979; Trefz et al., 1979) and in rats (Milstien & Kaufman, 1975b) , but also in vitro in the perfused rat liver preparation (Youdim et al., 1975; Woods & Youdim, 1977) and in liver slices (Milstien & Kaufman, 1975a [4-3Hlphenylalanine migrates to the C-3 position as a result of hydroxylase activity (the 'NIH shift'; ; only 8% is released directly as 3H20. When the resulting [3-3Hltyrosine is further metabolized through homogentisate oxidase [homogentisate :oxygen 1,2-oxidoreductase (decyclizing), EC 1.13.11.51, all 3H appears as 3H20. Label is released from (3-3H)-labelled intermediates between phenylalanine and homogentisate by treatment of cell extracts with N-iodosuccinimide. Calculation can thus provide values for both hydroxylase activity and flux through homogentisate.
The time courses of phenylalanine hydroxylation, p-hydroxyphenylpyruvate decarboxylation, homogentisate oxidation and formation of phenylalanine transamination products are shown in Fig. 1 . These experiments were performed with 504uM-phenylalanine, a concentration slightly lower than that reported for rat plasma (Herbert et al., 1966) . Rates for the three steps of phenylalanine oxidation were linear for at least 30min and then decreased. The reasons for this non-linearity are not known. It is possible that some role is played by the change in specific radioactivities brought about by release of unlabelled phenylalanine and tyrosine by proteolysis. The hepatocyte breaks down approx. 4% of its protein per hour under conditions comparable with those used in the present paper (Seglen, 1975) . The impact of such proteolysis may, however, be lessened if the amino acids so derived do not equilibrate rapidly with the extracellular pool (see Mortimore et al., 1972; Vidrich et al., 1977; Ward & Mortimore, 1978) ; it should, in any case, be quite small for phenylalanine itself because radiochemical dilution in the relatively large extracellular pool will naturally be rather slow.
The lower rate of tyrosine catabolism (relative to phenylalanine hydroxylation) may be again, in part, attributable to dilution of labelled tyrosine with endogenously-derived amino acid. Measurements of intracellular tyrosine after 5, 10 and 15min of incubation show that, at 50#uM-phenylalanine, the cellular content is constant at 0.02 + 0.01 nmol/mg dry wt., and that, at 1 mM-phenylalanine, this rises to Vol. 198 0.06 + 0.01 nmol/mg dry wt. A proportion of the phenylalanine may, however, appear as tyrosine released into the medium (Woods & Youdim, 1977) ; the extent of this depends on the activity of tyrosine aminotransferase (L-tyrosine: 2-oxoglutarate aminotransferase, EC 2.6.1.5), the rate-limiting step for tyrosine breakdown (Dickson et al., 1981 (Dickson et al., 1981) .
Accumulation of homogentisate in isolated cell incubations has previously been noted (Jones & Mason, 1978) . This is consistent with the observation here that the rates of homogentisate oxidation appear to be less than those of its formation. This does not seem to occur in the perfused liver (Woods & Youdim, 197 and may therefore reflect the properties tisate oxidase in isolated cells. The speci this enzyme is, nevertheless, similar in and in vivo (Jones & Mason, 1978 (Martin et al., 1979) . The which phenylacetate is formed probe phenylethylamine as an intermediate Blau, 1972; Blau, 1979) , although for phenylpyruvate has also been propose al., 1972). The rate of phenylethylamin is, however, relatively low (Haley & H despite a previous report to the contra al., 1974); phenylacetate itself is not o: rat (Haley & Harper, 1978) . In additio shown that very little phenylacetate is I liver in vivo (Edwards & Blau, 1972 '7), however, concentration of [4-3Hlphenylalanine and phenyl-, of homogenalanine hydroxylase flux (Hill coefficient = 2.7). This ific activity of resembles the response previously observed in vitro hepatocytes (Fisher & Kaufman, 1973; Dhondt et al., 1978) and indicates that the lipoprotein fractions (Fisher & ansamination Kaufman, 1973) and protein stimulators in rat liver if label from (Bessman & Huzino, 1969; Kaufman, 1970) are not lacking the effective, at least under the conditions in our and phenylexperiments. The rate at 1.0mM-phenylalanine is vill also be very similar to that reported previously by Woods & intermediate Youdim (1977) . The apparent Km for phenylalanine vivo, a small is approx. 0.2mm. This compares with values of rlalanine ad-1.5 mm (Youdim et al., 1975) and 0.2-0.3mM tate or its (Milstien & Kaufman, 1975a) . The similarity of this pathway by value to the Km of the enzyme with tetrahydroably involves biopterin as cofactor (Fisher & Kaufman, 1972) (Edwards & supports the view that this latter compound is the rmation from naturally-effective cofactor. d (Curtius et Glucagon (lOnM) stimulates hydroxylase activity ie production very markedly at lower, physiological, conIarper, 1978) centrations of phenylalanine (Fig. 2) , but has little try (David et effect at higher concentrations. This is consistent xidized in the with the observation that the enzyme is phosin, it has been phorylated in vivo by a cyclic AMP-dependent formed in the protein kinase (Donlon & Kaufman, 1978; Abita et I) and in the al., 1980) , and that such phosphorylation is accom-
1., 1976). It panied by increased activity under physiological
Se this com-conditions within the liver cell.
ice it will be Brand & Harper (1974a) have proposed that used).
glucagon stimulation of flux may be caused between the primarily by an increase in dihydropteridine reductase (NADPH: 6,7-dihydropteridine oxidoreductase, EC 1.6.99.7) activity. The increase in activity of this enzyme is, however, slow (>1 day); the rapid effects of glucagon in our experiments do not support this suggestion. The effect of glucagon and experimental diabetes on various parameters are shown in Table 1 . Glucagon is without effect at 1 mM-phenylalanine, but stimulates flux through all the segments of the catabolic pathway at 50OM-substrate. The flux through phenylalanine: pyruvate transaminase [Lphenylalanine (L-histidine): pyruvate aminotransferase, EC 2.6.1.581 is, however, insensitive to glucagon over the time period studied (see also Fig.   1 ). Although the activity of the* transaminase is 0-05 increased very markedly by glucagon over several 05 H-days (Brand & Harper, 1974b) , an effect associated 0.5 1.0
with an increase in enzyme protein (Shih & Chan, 1979) , no parallel increase in flux can be demonie hydroxylase strated (Brand & Harper, 1974b diabetes on this system in liver have not previously been studied, the direction of the changes is that expected by analogy with the increase of other enzymes of amino acid metabolism. Paradoxically, insulin has been reported to cause an increase in phenylalanine hydroxylase activity in one liverderived cell line (Tourian, 1976) . Glucagon increases the activity of the hydroxylase still further in hepatocytes from diabetic rats; this is consistent with the hypothesis that the amount of enzyme protein is increased in such cells.
Changes in the concentration of tetrahydrobiopterin are potentially also significant in the regulation of phenylalanine hydroxylase. Addition of this cofactor to liver slices increases enzyme activity (Milstien & Kaufman, 1975a) , suggesting that the enzyme may not be fully saturated in this preparation. Although most biopterin in liver is in the fully reduced form (Kaufman, 1964) , the concentration is only approx. 13,UM (calculated from the results of Fukushima & Nixon, 1980) . The Km for the cofactor is as yet unresolved, values of 4.5,M (Kaufman, 1971 ) and 23pM (Ayling et al., 1974) having been reported; the concentration of enzyme itself may also influence this parameter (Milstien & Kaufman, 1975a) . Brand & Harper (1974a) were, however, unable to show any change in cofactor availability in glucagon-treated rat liver cytoplasm. It therefore seems improbable that the results of the present study are explicable on the basis of changes in tetrahydrobiopterin content, although we cannot exclude this mechanism.
Another possible alternative is that glucagon might stimulate phenylalanine transport into the cell with a consequent increase in the intracellular concentration of the amino acid, leading secondarily to greater flux through the hydroxylase. It is claimed, however, that rat liver cells possess amino acid transport systems similar to those described for other cells (Le Cam & Freychet, 1977) . Phenylalanine is believed to be transported almost exclusively by the L-system (Christensen, 1969) and not to be concentrated against the gradient (Oxender & Christensen, 1963) . In addition, we have recently shown that tyrosine is not concentrated in liver cells incubated under similar conditions to those described in the present paper (Dickson et al., 1981) . It therefore seems improbable that hormone action is exerted at the level of membrane transport.
